Lenvaxen 10 mg (Lenvatinib) is an innovative oral medication designed to treat several types of advanced cancers, including thyroid cancer, renal cell carcinoma (RCC), and hepatocellular carcinoma (HCC). The active ingredient, Lenvatinib, is a multi-targeted tyrosine kinase inhibitor (TKI) that works by blocking the signals that promote the growth of cancer cells and the formation of blood vessels that supply…
Lenvaxen 4mg (Lenvatinib) is a powerful, targeted cancer therapy specifically designed to treat advanced thyroid cancer, hepatocellular carcinoma (liver cancer), and renal cell carcinoma (kidney cancer). This innovative medication inhibits specific proteins that promote tumour growth and spread, slowing cancer progression. Lenvaxen 4mg has become a trusted choice for oncologists worldwide due to its efficacy in targeting multiple cancer types,…
Sunitix (Sunitinib) is a powerful oral medication used to treat several types of advanced cancers, including renal cell carcinoma (RCC), gastrointestinal stromal tumours (GIST), and pancreatic neuroendocrine tumours (pNET). Sunitinib, the active ingredient in Sunitix, is a multi-targeted tyrosine kinase inhibitor (TKI) that works by blocking the activity of specific enzymes that promote cancer cell growth and angiogenesis. The process…
